Allwood, B WB WAllwoodNightingale, RRNightingaleAgbota, GGAgbotaAuld, SSAuldBisson, G PG PBissonByrne, AAByrneDunn, RRDunnEvans, DDEvansHoddinott, GGHoddinottGünther, GunarGunarGüntherIslam, ZZIslamJohnston, J CJ CJohnstonKalyatanda, GGKalyatandaKhosa, CCKhosaMarais, SSMaraisMakanda, GGMakandaMashedi, O MO MMashediMeghji, JJMeghjiMitnick, CCMitnickMulder, CCMulderNkereuwem, EENkereuwemNkereuwem, OONkereuwemOzoh, O BO BOzohRachow, AARachowRomanowski, KKRomanowskiSeddon, J AJ ASeddonSchoeman, IISchoemanThienemann, FFThienemannWalker, N FN FWalkerWademan, D TD TWademanWallis, RRWallisvan der Zalm, M MM Mvan der Zalm2024-10-262024-10-262024-03https://boris-portal.unibe.ch/handle/20.500.12422/178788In 2020, it was estimated that there were 155 million survivors of TB alive, all at risk of possible post TB disability. The 2nd International Post-Tuberculosis Symposium (Stellenbosch, South Africa) was held to increase global awareness and empower TB-affected communities to play an active role in driving the agenda. We aimed to update knowledge on post-TB life and illness, identify research priorities, build research collaborations and highlight the need to embed lung health outcomes in clinical TB trials and programmatic TB care services. The symposium was a multidisciplinary meeting that included clinicians, researchers, TB survivors, funders and policy makers. Ten academic working groups set their own goals and covered the following thematic areas: 1) patient engagement and perspectives; 2) epidemiology and modelling; 3) pathogenesis of post-TB sequelae; 4) post-TB lung disease; 5) cardiovascular and pulmonary vascular complications; 6) neuromuscular & skeletal complications; 7) paediatric complications; 8) economic-social and psychological (ESP) consequences; 9) prevention, treatment and management; 10) advocacy, policy and stakeholder engagement. The working groups provided important updates for their respective fields, highlighted research priorities, and made progress towards the standardisation and alignment of post-TB outcomes and definitions.enSymposium advocacy post-tuberculosis proceedings research600 - Technology::610 - Medicine & healtharticle10.48350/1985653896640610.5588/ijtldopen.23.0619